-

Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs

New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds

WALTHAM, Mass.--(BUSINESS WIRE)--To support a wider range of ion chromatography analysis with one instrument, Thermo Fisher Scientific Inc., today launched the Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes. The new analytical instrument is designed to be easily reconfigurable, providing those who require determination of ionic and small polar compounds with a one stop shop for consistent, reliable ion analysis.

As safety concerns increase around our environment, particularly our food and water supply, scientists will require versatile and sensitive instruments for adequate testing and analysis. Aligned with Thermo Fisher’s mission to enable our customers to make the world healthier, cleaner and safer, the Dionex Inuvion IC system equips environmental, industrial, municipal water, and food and beverage labs with the necessary equipment to determine ionic contaminants in water. The technology also helps identify corrosive contaminants in oil and gas, as well as provide quality assurance and quality control of small ionic compounds in food, beverage, and pharmaceuticals.

The Dionex Inuvion system helps meet labs’ needs to operate more efficiently with easily configurable workflows and a small footprint. The flexible platform can be tailored to meet current analytical requirements and helps extend IC capabilities to adapt to changing sample types and workflow requirements in the future more easily and cost-effectively.

“As the originator of ion chromatography, we continue to lead innovation in all areas of instrumentation and column chemistry to meet our customers’ growing needs for better resolution, faster results, and intuitive lab experience,” said Lidija Raicevic, vice president and general manager of Ion Chromatography and Sample Preparation at Thermo Fisher Scientific. “The Dionex Inuvion system is built on years of expertise and this new system will provide enhanced capabilities to labs of all sizes while helping streamline our IC portfolio so labs can more easily find the technology that is best for their needs.”

The Dionex Inuvion IC system features new advanced pump technology that improves speed, quality, and reproducibility; operator-friendly engineering to enhance the operator experience; and user-installable accessories that extend its capabilities and ultimately help achieve the highest quality results.

For more information about the Dionex Inuvion IC system, including technical specifications and applications, please visit www.thermofisher.com/inuvion.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media:
Laura Bright
Laura.Bright@thermofisher.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media:
Laura Bright
Laura.Bright@thermofisher.com

More News From Thermo Fisher

Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product manufacturing. The terms of the deal were not disclosed. Under the agreement, Thermo Fisher will acquire Sanofi’s steriles manufacturing site in Ridgefield, New Jersey and will continue to manufacture a portfolio of therapies for Sanofi. In addition, Thermo Fisher will expand...

Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine

CARLSBAD, Calif.--(BUSINESS WIRE)--Today, Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* helping accelerate precision oncology research. The Oncomine Comprehensive Assay Plus detects a broad range of genomic alterations in 517 genes and will now be able to deliver comprehensive genomic profiling (CGP) results as soon as the next day, enabled by Ion Torrent technology and easy, automated workflows. CGP facilit...

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on October 15, 2025, to shareholders of record as of September 15, 2025. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world h...
Back to Newsroom